Paka Pulmonary Pharmaceuticals

Eloxx Pharmaceutical is a cutting-edge biopharmaceutical company based in Waltham, MA, specializing in the development of small molecule genetic therapies. With a scientific focus on correcting nonsense mutations and ribosomal mutations, their platform technologies have the potential to revolutionize the treatment of rare genetic diseases and cancer. Driven by their commitment to innovation, Eloxx is currently focused on developing CELX-02, a novel therapy for Alport Syndrome, a rare kidney disease. Their pipeline also includes promising treatments for other conditions such as RDEB, JEB, and FAP, all targeting the underlying genetic defects responsible for these diseases. With a strong emphasis on scientific research and development, Eloxx Pharmaceuticals is poised to make a significant impact in the field of genetic medicine.Generated from the website

Recovery Pharmaceuticals is a company based in Wayland, MA that specializes in developing innovative solutions for the healthcare industry. With a focus on research and development, the company is committed to creating pharmaceutical products that aim to improve patient outcomes and quality of life. Generated from their business information

Acer Therapeutics Inc is a biopharmaceutical company based in Newton, MA. Specializing in the development and commercialization of innovative therapies for rare and life-threatening diseases, Acer Therapeutics Inc focuses on addressing unmet medical needs in niche patient populations. With a commitment to advancing scientific research and delivering impactful treatments, Acer Therapeutics Inc strives to make a meaningful difference in the lives of those affected by rare diseases. Through their dedication to improving patient outcomes, the company remains at the forefront of pioneering medical advancements. Generated from their business information